The store will not work correctly when cookies are disabled.
4-(3-Aminophenoxy)-N-(5-methylthiazol-2-yl)butanamide
ID: ALA4533193
PubChem CID: 155547368
Max Phase: Preclinical
Molecular Formula: C14H17N3O2S
Molecular Weight: 291.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cnc(NC(=O)CCCOc2cccc(N)c2)s1
Standard InChI: InChI=1S/C14H17N3O2S/c1-10-9-16-14(20-10)17-13(18)6-3-7-19-12-5-2-4-11(15)8-12/h2,4-5,8-9H,3,6-7,15H2,1H3,(H,16,17,18)
Standard InChI Key: SOTLMSCXGWXEGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
9.5614 -27.3140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5602 -28.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2683 -28.5425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9779 -28.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9751 -27.3104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2665 -26.9051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8536 -26.9055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1460 -27.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4381 -26.9059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7305 -27.3146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0227 -26.9062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3151 -27.3150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0225 -26.0890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6073 -26.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5206 -26.0955 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.7212 -25.9258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3128 -26.6336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8598 -27.2407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3887 -25.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6813 -26.8991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
16 19 1 0
5 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.38 | Molecular Weight (Monoisotopic): 291.1041 | AlogP: 2.83 | #Rotatable Bonds: 6 |
Polar Surface Area: 77.24 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.08 | CX Basic pKa: 3.85 | CX LogP: 2.41 | CX LogD: 2.33 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.63 | Np Likeness Score: -2.02 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |